Cited by 377Antifungal resistance and susceptibilityFungal Infections and StudiesFungal Plant Pathogen Control

The DOI matches its Crossref record; 922 of the 930 references it cites were found in a registry or an index.

Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development

Groll, Andreas H., Piscitelli, Stephen C., Walsh, Thomas J.·1998·Advances in pharmacology

DOI 10.1016/s1054-3589(08)60129-5

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s1054-3589(08)60129-5

Cites

922 of 922 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
POLYAMINES
Tabor, C. W., & Tabor, H. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.003533 · Cited by 3,111
DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
Liu, L. F. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002031 · Cited by 1,805
Cell Wall Chemistry, Morphogenesis, and Taxonomy of Fungi
Bartnicki-García, S. (1968) · Annual Review of Microbiology · doi:10.1146/annurev.mi.22.100168.000511 · Cited by 1,569
A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,164
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Peptide antibiotics
Hancock, R. E. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,098

Show all 930 references

Research works printed but not linked: 18

Atkinson, 1969, Pharmacokinetics of intrathecal administered amphotericin B., Am. Rev. Respir. Dis., 99, 917
Benhamu, 1991, Does ketoconazole prevent fungal infection in children treated with high-dose chemotherapy and bone-marrow transplantation?, Bone Marrow Transplant., 7, 127
Bernardo, 1994, The effect of L-arginine on amphotericin B-induced nephrotoxicity., J. Am. Soc. Nephrol., 5, 917
Brammer, 1987, A review of the pharmacokinetics of fluconazole (UK-49,858) in laboratory animals and man, 141
Feldman, 1992, The use of granulocyte-stimulating factor (GCSF) enhanced granulocyte transfusions from normal donors in patients with neutropenia related fungal infections, Blood, 80, 414a
G. Gaenger, G. Just-Nuebling, M. Eichel, R. Hoika, W. Stille (1993). Itraconazole solution in patients with non-response to fluconazole. In Abstracts of the IXth International Conference on AIDS, abstract 1394.
Gascoigne, 1981, The kinetics of ketoconazole in animals and man., Clin. Res. Rev., 1, 177
Gelfand, 1988, Amphotericin B treatment of human mononuclear cells in vitro results in secretion of tumor necrosis factor and interleukin-1., Clin. Res., 36, 456
Graybill, 1982, Ketoconazole therapy for systemic fungal infections: Inadequacy of standard dose regimens., Am. Rev. Respir. Dis., 126, 171
Gupta, 1994, Antifungal agents: An overview. Part II., J. Am. Acad. Dermatol., 30, 911, 10.1016/S0190-9622(94)70112-1 · DOI
Hiemenz, 1995, Emergency use of amphotericin B lipid complex (ABLC) in the treatment of patients with aspergillosis historical control comparison with amphotericin B, Blood, 86, 849a
Jolidon, 1993, 2,3 oxidosqualene-lanosterol cyclase, an attractive target for antifungal drug design.
Moore, 1995, Hematopoietic reconstitution: New approaches., Clin. Cancer Res., 1, 3
Peeters, 1986, Itraconzole, a new orally active triazole derivative for treatment of vaginal candidosis., Curr. Ther. Res., 39, 496
Plempel, 1988, Antimycotic effects of BAY R 3783 in vitro and on dermatophytoses and opportunistic mycoses of the organs in vivo, Rev. lb. Micol., 5, 0
Ringden, 1993, Clinical experience with AmBisome with special emphasis on experience with children., Bone Marrow Transplant., 12, S149
Schaude, 1988, Biological activity of SDZ 89485 in animal models., Rev. lb. Micol., 5, P51
Shepard, 1986, Cyclosporin-ketoconazole: A potentially dangerous drug interaction., Clin. Pharmacol., 6, 468

Sorted by citations

Items 101–200 of 377

Therapeutic targets for the treatment of microsporidiosis in humans
Han, B., & Weiss, L. M. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1538360 · Cited by 64
In search of the holy grail of antifungal therapy.
Chapman, S. W., Sullivan, D. C., & Cleary, J. D. (2008) · PubMed Central · Cited by 64
Identification of Essential Genes in the Human Fungal Pathogen Aspergillus fumigatus by Transposon Mutagenesis
Firon, A., Villalba, F., Beffa, R., & d’Enfert, C. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.2.247-255.2003 · Cited by 64
Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far
Kontoyiannis, D. P., & Lewis, R. E. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.08.003 · Cited by 62
Ocular Distribution of Intravenously Administered Lipid Formulations of Amphotericin B in a Rabbit Model
Goldblum, D., Rohrer, K., Frueh, B. E., Theurillat, R., Thormann, W., & Zimmerli, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3719-3723.2002 · Cited by 63
Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.
Luo, G., Ibrahim, A. S., French, S. W., Edwards, J. E., & Fu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025909 · Cited by 62
“Notwithstanding current antifungal therapy [3,4,5], mortality remains unacceptably high [6,7,8].”
Background
Systemic Antifungal Agents: Current Status and Projected Future Developments
Seyedmousavi, S., Rafati, H., İlkit, M., Tolooe, A., Hedayati, M. T., & Verweij, P. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_5 · Cited by 62
Invasive Aspergillosis in Patients with Hematologic Malignancies
Wiederhold, N. P., Lewis, R. E., & Kontoyiannis, D. P. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.15.1592.31965 · Cited by 58
Traditional and Emerging Antifungal Therapies
Arnold, T. M., Dotson, E. K., Sarosi, G. A., & Hage, C. A. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200906-048al · Cited by 57
Design, Synthesis and Antifungal Activity of Novel Benzofuran-Triazole Hybrids
Liang, Z., Xu, H., Tian, Y., Guo, M., Su, X., & Guo, C. (2016) · Molecules · doi:10.3390/molecules21060732 · Cited by 57
Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
T., B., W., F., H., B., N., B., K.-H., D., M., H., D., H., U., J., G., J.-N., M., K., et al. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0730-4 · Cited by 53
Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients
Pieper, S., Kolve, H., Gumbinger, H., Goletz, G., Würthwein, G., & Groll, A. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks258 · Cited by 53
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 55
Combination antifungal therapy for invasive fungal infections in children and adults
Hatipoğlu, N., & Hatipoğlu, H. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.29 · Cited by 50
Recent Advances in Antifungal Prevention and Treatment
Groll, A. H., & Tragiannidis, A. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.03.003 · Cited by 48
Drug-Induced Acute Myocardial Infarction: Identifying ‘Prime Suspects’ from Electronic Healthcare Records-Based Surveillance System
Coloma, P. M., Schuemie, M. J., Trifirò, G., Furlong, L. I., van Mulligen, E. M., Bauer‐Mehren, A., Avillach, P., Kors, J. A., Sanz, F., Mestres, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072148 · Cited by 49
Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients
Würthwein, G., Young, C., Lanvers‐Kaminsky, C., Hempel, G., Trame, M. N., Schwerdtfeger, R., Ostermann, H., Heinz, W., Cornely, O. A., Kolve, H., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00265-11 · Cited by 48
Update on antifungal agents for paediatric patients
Groll, A. H., & Tragiannidis, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03334.x · Cited by 48
Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis
Takemoto, K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh055 · Cited by 47
Antifungal activity and pore-forming mechanism of astacidin 1 against Candida albicans
Choi, H., & Lee, D. G. (2014) · Biochimie · doi:10.1016/j.biochi.2014.06.014 · Cited by 46
Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a New In Vitro Pharmacokinetic/Pharmacodynamic Model
Meletiadis, J., Al‐Saigh, R., Velegraki, A., Walsh, T. J., Roilides, E., & Zerva, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00662-11 · Cited by 45
Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis
Takemoto, K., Yamamoto, Y., Ueda, Y., Sumita, Y., Yoshida, K., & Niki, Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl005 · Cited by 44
Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children
Gastine, S., Lehrnbecher, T., Müller, C., Farowski, F., Bader, P., Ullmann-Moskovits, J., Cornely, O. A., Groll, A. H., & Hempel, G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01194-17 · Cited by 44
Posaconazole: a new broad-spectrum antifungal agent
Kwon, D. S., & Mylonakis, E. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1167 · Cited by 44
Synthesis and antifungal activity of substituted-10-methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indoles
Tiwari, R. K., Verma, A. K., Chhillar, A. K., Singh, D., Singh, J., Sankar, V. K., Yadav, V., Sharma, G. L., & Chandra, R. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.054 · Cited by 44
Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
Groll, A. H., Silling, G., Young, C., Schwerdtfeger, R., Ostermann, H., Heinz, W., Gerß, J., Kolve, H., Lanvers‐Kaminsky, C., Pinheiro, J. P. V., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-10 · Cited by 44
Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis
Alvarez, C. A., Wiederhold, N. P., McConville, J. T., Peters, J. I., Najvar, L. K., Graybill, J. R., Coalson, J. J., Talbert, R. L., Burgess, D. S., Bocanegra, R., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.01.014 · Cited by 43
Study of the toxicity of a new lipid complex formulation of amphotericin B
Larabi, M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh025 · Cited by 43
Acrophialophora fusisporaBrain Abscess in a Child with Acute Lymphoblastic Leukemia: Review of Cases and Taxonomy
Al-Mohsen, I. Z., Sutton, D. A., Sigler, L., Almodovar, E., Mahgoub, N., Frayha, H. H., Al-Hajjar, S. H., Rinaldi, M. G., & Walsh, T. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4569-4576.2000 · Cited by 43
Mycoses in Pediatric Patients
Steinbach, W. J., & Walsh, T. J. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.006 · Cited by 41
Agents for treatment of invasive fungal infections
Luna, B., Drew, R. H., & Perfect, J. R. (2000) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(00)80005-5 · Cited by 40
New potential targets for antifungal development
Wills, E. A., Redinbo, M. R., Perfect, J. R., & Poeta, M. D. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.3.265 · Cited by 41
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
Meletiadis, J., Chanock, S. J., & Walsh, T. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-05 · Cited by 40
Micafungin: pharmacology, experimental therapeutics and clinical applications
Groll, A. H., Stergiopoulou, T., Roilides, E., & Walsh, T. J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.4.489 · Cited by 39
Current Therapy and Therapeutic Targets for Microsporidiosis
Wei, J., Fei, Z., Pan, G., Weiss, L. M., & Zhou, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.835390 · Cited by 41
Emerging fungal diseases: the importance of the host
Procop, G. W., & Roberts, G. D. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.05.004 · Cited by 37
Pharmacotherapy of onychomycosis
Baran, R., Gupta, A. K., & Pierard, G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.4.609 · Cited by 37
High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies
Groll, A. H., Mickiene, D., Werner, K., Piscitelli, S. C., & Walsh, T. J. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00396-5 · Cited by 35
FTR1335 Is a Novel Synthetic Inhibitor of Candida albicans N(-)Myristoyltransferase with Fungicidal Activity
Ebara, S., Naito, H., Nakazawa, K., Ishii, F., & Nakamura, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.591 · Cited by 34
Pharmacokinetics and Buccal Mucosal Concentrations of a 15 Milligram per Kilogram of Body Weight Total Dose of Liposomal Amphotericin B Administered as a Single Dose (15 mg/kg), Weekly Dose (7.5 mg/kg), or Daily Dose (1 mg/kg) in Peripheral Stem Cell Transplant Patients
Gubbins, P. O., Amsden, J. R., McConnell, S. A., & Anaissie, E. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01448-08 · Cited by 33
Diagnose und Therapie von Pilzinfektionen und der Pneumozystis-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen
Groll, A. H., & Ritter, J. (2005) · Klinische Pädiatrie · doi:10.1055/s-2005-872501 · Cited by 32
Fluconazole Prophylaxis in the Very Low Birth Weight Infant: Not Ready for Prime Time
Neely, M. N., & Schreiber, J. R. (2001) · PEDIATRICS · doi:10.1542/peds.107.2.404 · Cited by 33
Evaluation of Antifungal Pharmacodynamic Characteristics of AmBisome against Candida albicans
Takemoto, K., Yamamoto, Y., & Ueda, Y. (2006) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2006.tb03832.x · Cited by 33
Safety and Efficacy of Multilamellar Liposomal Nystatin against Disseminated Candidiasis in Persistently Neutropenic Rabbits
Groll, A. H., Petraitis, V., Petraitienė, R., Field‐Ridley, A., Calendario, M., Bacher, J., Piscitelli, S. C., & Walsh, T. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2463 · Cited by 33
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte–macrophage progenitor cells in vitro
Benkoo, I. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.5.675 · Cited by 31
Role of Newer Azoles in Surgical Patients
Patterson, T. F. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.6.504 · Cited by 31
Cryptococcal Peritonitis Complicating Hepatic Failure: Case Report and Review of the Literature.
Saif, M. W., & Raj, M. (2006) · PubMed · Cited by 30
Antifungals and their use in veterinary ophthalmology
Ford, M. M. (2004) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2003.12.002 · Cited by 30
Effects of topical Amphotericin B on expression of cytokines in nasal polyps
Shin, S., & Ye, M. (2004) · Acta Oto-Laryngologica · doi:10.1080/00016480410017404 · Cited by 30
New developments in chemotherapy for non-invasive fungal infections
Hossain, M. A., & Ghannoum, M. A. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.8.1501 · Cited by 30
Distribution of Lipid Formulations of Amphotericin B into Bone Marrow and Fat Tissue in Rabbits
Groll, A. H., Mickiene, D., Piscitelli, S. C., & Walsh, T. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.408-410.2000 · Cited by 30
Synthesis and biological activities of piperazine derivatives as antimicrobial and antifungal agents
(2017) · Organic Communications · doi:10.25135/acg.oc.23.17.05.026 · Cited by 29
Keratitis caused by candida glabrata in a patient with chronic granulomatous disease
Djalilian, A. R., Smith, J. A., Walsh, T. J., Malech, H. L., & Robinson, M. R. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01091-1 · Cited by 29
Carum copticum and Thymus vulgaris oils inhibit virulence in Trichophyton rubrum and Aspergillus spp
Khan, M. S., Ahmad, I., & Cameotra, S. S. (2014) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822014000200021 · Cited by 29
Antifungal Therapeutic Drug Monitoring
Lewis, R. E. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0023-9 · Cited by 29
Study of amphotericin B magnetic liposomes for brain targeting
Zhao, M., Hu, J., Zhang, L., Zhang, L., Sun, Y., Ma, N., Chen, X., & Gao, Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.035 · Cited by 29
Extended Dosing Regimens for Fungal Prophylaxis
Lehrnbecher, T., Bochennek, K., Klingebiel, T. E., Gastine, S., Hempel, G., & Groll, A. H. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-19 · Cited by 29
Compartmental Pharmacokinetics and Tissue Distribution of Multilamellar Liposomal Nystatin in Rabbits
Groll, A. H., Mickiene, D., Werner, K., Petraitienė, R., Petraitis, V., Calendario, M., Field‐Ridley, A., Crisp, J., Piscitelli, S. C., & Walsh, T. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.950-957.2000 · Cited by 29
A Clinical Perspective for the Management of Invasive Fungal Infections: Focus on IDSA Guidelines
Kontoyiannis, D. P. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.12.175s.34506 · Cited by 29
Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products
Liu, Y., Mei, Z., Mei, L., Tang, J., Yuan, W., Srinivasan, S., Ackermann, R., & Schwendeman, A. S. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.09.008 · Cited by 28
Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy
Balhara, M., Chaudhary, R., Ruhil, S., Singh, B., Dahiya, N. R., Parmar, V. S., Jaiwal, P. K., & Chhillar, A. K. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254196 · Cited by 29
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994–1999
Chandrasekar, P. H., Cutright, J. L., & Manavathu, E. K. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00295-4 · Cited by 28
Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis
Wang, Y., Jia, X., Jia, J., Li, M., Cao, Y., Gao, P., Liao, W., Cao, Y., & Jiang, Y. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05187.x · Cited by 26
Defining Targets for Investigating the Pharmacogenomics of Adverse Drug Reactions to Antifungal Agents
Meletiadis, J., Chanock, S. J., & Walsh, T. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.561 · Cited by 27
Application of target repositioning and in silico screening to exploit fatty acid binding proteins (FABPs) from Echinococcus multilocularis as possible drug targets
Bélgamo, J. A., Alberca, L. N., Pórfido, J. L., Romero, F. N. C., Rodrı́guez, S., Talevi, A., Córsico, B., & Franchini, G. R. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00352-8 · Cited by 25
Allicin-induced global gene expression profile of Saccharomyces cerevisiae
Yu, L., Guo, N., Meng, R., Liu, B., Tang, X., Jin, J., Cui, Y., & Deng, X. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2709-x · Cited by 25
Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds
Scalese, G., Mosquillo, M. F., Pérez‐Díaz, L., & Gambino, D. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215608 · Cited by 24
Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Lim, W., Verbon, A., & van de Sande, W. W. J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2080195 · Cited by 24
Dental management of the head & neck cancer patient treated with radiation therapy.
Murdoch‐Kinch, C. A., & Zwetchkenbaum, S. R. (2011) · PubMed · Cited by 24
Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design
Mabanglo, M. F., Hast, M. A., Lubock, N. B., Hellinga, H. W., & Beese, L. S. (2013) · Protein Science · doi:10.1002/pro.2411 · Cited by 24
Influence of the Progression of Cryptococcal Meningitis on Brain Penetration and Efficacy of AmBisome in a Murine Model
Takemoto, K., Yamamoto, Y., & Ueda, Y. (2006) · Chemotherapy · doi:10.1159/000095820 · Cited by 24
HMG-CoA Reductase Inhibitors as Drug Leads against Naegleria fowleri
Hahn, H. J., Abagyan, R. A., Podust, L. M., Roy, S., Ali, I. K. M., & Debnath, A. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00428 · Cited by 23
Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis
Xin, H. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.035 · Cited by 24
Therapeutic Guidelines in Systemic Fungal Infections
Richardson, & Bl, J. (2003) · Cited by 24
Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy
Chiou, C. C., Groll, A. H., Mavrogiorgos, N. C., Wood, L. V., & Walsh, T. J. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200205000-00008 · Cited by 23
Antifungal Drugs for the Treatment of Invasive Fungal Infections—A Limited Therapeutic Toolbox Facing Growing Resistances
Susan, V., Lang, M., Sabou, M., & Bourel‐Bonnet, L. (2025) · Pharmaceuticals · doi:10.3390/ph18081220 · Cited by 28
Therapeutic Potential of Green Synthesized Gold Nanoparticles Using Extract of Leptadenia hastata against Invasive Pulmonary Aspergillosis
Abdallah, B. M., & Ali, E. M. (2022) · Journal of Fungi · doi:10.3390/jof8050442 · Cited by 22
Clinical pharmacology of antifungal agents in pediatric patients
Chiou, C. C., Walsh, T. J., & Groll, A. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.15.2465 · Cited by 22
Cladophialophora bantiana Brain Abscess in an Immunocompetent Patient
Revankar, S. G. (2011) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2011/642517 · Cited by 22
Anticancer and Antimicrobial Potential of Plant-Derived Natural Products
Hadi, W. (2011) · InTech eBooks · doi:10.5772/26077 · Cited by 22
Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits
Groll, A. H., Mickiene, D., Petraitis, V., Petraitienė, R., Kelaher, A. M., Sarafandi, A. A., Würthwein, G., Bacher, J. D., & Walsh, T. J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki287 · Cited by 22
Comparative Toxicities and Pharmacokinetics of Intrathecal Lipid (Amphotericin B Colloidal Dispersion) and Conventional Deoxycholate Formulations of Amphotericin B in Rabbits
Clemons, K. V., Sobel, R. A., Williams, P. L., & Stevens, D. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.612-615.2001 · Cited by 22
Global gene expression profile of Saccharomyces cerevisiae induced by dictamnine
Guo, N., Yu, L., Meng, R., Fan, J., Wang, D., Sun, G., & Deng, X. (2008) · Yeast · doi:10.1002/yea.1614 · Cited by 22
Managing drug interactions in the patient with aspergillosis
Lewis, R. E. (2006) · Medical Mycology · doi:10.1080/13693780600835724 · Cited by 21
In Vitro Antifungal Activity and Probable Fungicidal Mechanism of Aqueous Extract of Barleria Grandiflora
Kumari, S., Jain, P., Sharma, B., Kadyan, P., & Dabur, R. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1527-0 · Cited by 21
Therapy of infections caused by dematiaceous fungi
Revankar, S. G. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.4.601 · Cited by 21
Pharmacological Properties of Antifungal Drugs with a Focus on Anidulafungin
Mazzei, T., & Novelli, A. (2009) · Drugs · doi:10.2165/11315550-000000000-00000 · Cited by 21
Effect of Amphotericin B on the thermodynamic stability, aggregation state, hemolysis and antifungal activity of Amphotericin B-nonionic surfactant micellar system
Liu, L., Liang, Z., Zhou, Y., Pan, H., & Liu, H. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.121486 · Cited by 20
Isolation of a new broad spectrum antifungal polyene from Streptomyces sp. MTCC 5680
Vartak, A. P., Mutalik, V., Parab, R., Shanbhag, P., Bhave, S. V., Mishra, P. D., & Mahajan, G. (2014) · Letters in Applied Microbiology · doi:10.1111/lam.12229 · Cited by 19
Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity
Kontoyiannis, D. P., Lewis, R. E., Lionakis, M. S., Albert, N. D., May, G. S., & RAAD, I. I. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00136-6 · Cited by 19
Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature
Backer, M. D. D., Hoogt, R. D., Froyen, G., Odds, F. C., Simons, F. A., Contreras, R., & Luyten, W. H. M. L. (2000) · Microbiology · doi:10.1099/00221287-146-2-353 · Cited by 19
Itraconazole — perspectives for the management of invasive aspergillosis
Groll, A. H. (2002) · Mycoses · doi:10.1111/j.1439-0507.2002.tb04770.x · Cited by 19
Genome-wide piggyBac transposon-based mutagenesis and quantitative insertion-site analysis in haploid Candida species
Li, Z., Wang, H., Cai, C., Wong, A. H., Wang, J., Gao, J., & Wang, Y. (2020) · Nature Protocols · doi:10.1038/s41596-020-0351-3 · Cited by 18
Synthesis, Biological Evaluation and Molecular Docking of Certain Sulfones as Potential Nonazole Antifungal Agents
Farès, M., Said, M. A., Alsherbiny, M. A., Eladwy, R. A., Almahli, H., Abdel‐Aziz, M. M., Ghabbour, H. A., Eldehna, W. M., & Abdel‐Aziz, H. A. (2016) · Molecules · doi:10.3390/molecules21010114 · Cited by 18
Current experience with itraconazole in neutropenic patients: a concise overview of pharmacological properties and use in prophylactic and empirical antifungal therapy
Glasmacher, A. G., & Prentice, A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01609.x · Cited by 18
Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model
Khan, M. A., Faisal, S. M., & Owais, M. (2006) · Journal of drug targeting · doi:10.1080/10611860600720384 · Cited by 17
Antiarrhythmic drug amiodarone displays antifungal activity, induces irregular calcium response and intracellular acidification of Aspergillus niger – Amiodarone targets calcium and pH homeostasis of A. niger
Bagar, T., & Benčina, M. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.07.007 · Cited by 17
Salicylic acid resistance is conferred by a novel YRR1 mutation in Saccharomyces cerevisiae
Kodo, N., Matsuda, T., Doi, S., & Munakata, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.069 · Cited by 17
Status of combination therapy for refractory mycoses
Antoniadou, A., & Kontoyiannis, D. P. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00005 · Cited by 17
Comparative Drug Disposition, UrinaryPharmacokinetics, and Renal Effects of Multilamellar Liposomal Nystatinand Amphotericin B Deoxycholate inRabbits
Groll, A. H., Mickiene, D., Petraitis, V., Petraitienė, R., Alfaro, R. M., King, C., Piscitelli, S. C., & Walsh, T. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3917-3925.2003 · Cited by 17

Authors: Groll, A. H., Piscitelli, S. C., & Walsh, T. J.
Affiliations: National Institutes of Health (US)
ORCID: Groll, Andreas H.
Piscitelli, Stephen C.
Walsh, Thomas J.
Venue: Advances in pharmacology
Publisher: Elsevier
Published: 1998
Volume: 44
Pages: 343-500
ISSN: 1054-3589 (ISSN-L)
DOI: 10.1016/s1054-3589(08)60129-5
OpenAlex: W63281979
Cited by: 377
References: 930
Citations by year: 2026: 3 · 2025: 3 · 2024: 16 · 2023: 7 · 2022: 12 · 2021: 8 · 2020: 13 · 2019: 7 · 2018: 8 · 2017: 10 · 2016: 13 · 2015: 13 · 2014: 16 · 2013: 13 · 2012: 7
FWCI: 54.29
Type: book chapter
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advances in pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: systemic antifungal agents, clinical pharmacology, antifungal drug development, antifungal drug targets, fungal infection
MeSH terms: Animals, Antifungal Agents, Fungi, Humans, Mycoses, Triazoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks